|
|||||||||||||||||||||||||
![]() |
ThursdayAvicena Announces Promising Phase II Results From Parkinson's Disease Trial
MORElData demonstrated that neither PD-02 nor minocycline was found to be futile as compared to predetermined thresholds, suggesting both agents may be worthy of further consideration as potential therapeutics. Results from this study, which was sponsored by the National Institute of Neurological Disorders and Stroke (NIH/NINDS), were published today in the journal Neurology.
|